Suppression of latent transforming growth factor-β (TGF-β)-binding protein 1 (LTBP1) inhibits natural killer/ T cell lymphoma progression by inactivating the TGF-β/Smad and p38MAPK pathwaysRui Lin, Mingzhi Zhang, Xiaoli Li et al.|Experimental Cell Research|2021Cited by 29
The experience of diagnosis and treatment for TAFRO syndromeXiaolong Wu, Mingzhi Zhang, Xin Li et al.|Annals of Hematology|2023Cited by 8
SUV39H1 is a prognosis and immune microenvironment-related biomarker in diffuse large B-cell lymphomaYue Zhang, Qingjiang Chen, Siyu Qian et al.|Clinical & Translational Oncology|2023Cited by 6
<scp>MYC</scp> overexpression but not <scp>MYC</scp>/<scp>BCL2</scp> double expression predicts survival in bulky mass diffuse large B‐cell lymphoma patientsYanjie Wang, Qingjiang Chen, Donglin Liu et al.|Cancer Medicine|2023Cited by 6
Clinical features and prognosis of chronic natural killer cell lymphoproliferative disordersDonglin Liu, Xudong Zhang, Yanjie Wang et al.|Research Square|2023Cited by 0